Beclometasone Dipropionate, Glycopyrronium Bromide, Formoterol Fumarate Dihydrate

3 trials 1 recruiting RRespiratory

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

12 Countries

Phase II

Phase IV

Phase II: 1 Phase IV: 2

Indications tested

Sponsors using this IMP

Chiesi Farmaceutici S.p.A. 2 General Practitioners Research Institute B.V. 1

All trials

3 total

BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/… Pending

2025-524289-56-00 Phase IV 8 countries Chiesi Farmaceutici S.p.A.
Therapeutic equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in subjects with mild to moderate asthma (TRECONY) Recruiting

2025-521456-35-00 Phase II 8 countries Chiesi Farmaceutici S.p.A.
TRACkER trial Ended

2023-508300-37-00 Phase IV 1 country General Practitioners Research Institute B.V.

Showing 1–3 of 3 trials

← All drugs A–Z